FHTX — Foghorn Therapeutics Inc Com

Ownership history in Focus Partners Wealth  ·  3 quarters on record

This page tracks every 13F SEC filing in which Focus Partners Wealth reported a position in Foghorn Therapeutics Inc Com (FHTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2024 Q1)
Avg. % of fund
0.0%
First filed
2024 Q1
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 1,549 -214,141 -99.3% 0.00% $240K $4.89
2024 Q2 ADDED 215,690 +107,920 +100.1% 0.00% $1.3M $5.75
2024 Q1 INITIATED 107,770 — — 0.01% $632K —
% of Fund (quarterly)    FHTX price (monthly, adj. close)

Other funds also holding FHTX

As of 2025 Q4 — sorted by position size

Flagship Pioneering, LLC 3Y 7Y 21.12% Euclidean Capital LLC 3Y 2.3% BVF INC/IL 3Y 7Y 0.96% Birchview Capital, LP 3Y 7Y 0.89% DEERFIELD MANAGEMENT COMPANY, L.P. 3Y 7Y 0.25% DAFNA Capital Management LLC 3Y 7Y 0.16% Brummer Multi-Strategy AB 0.15% Siren, L.L.C. 0.12% Persistent Asset Partners Ltd 0.11% Sio Capital Management, LLC 3Y 7Y 0.1%
← Back to Focus Partners Wealth Holdings